A standard pediatric vaccine used to prevent several common types of life-threatening infections also effectively reduced the rates of pneumococcal meningitis in children and adults, according to a new study in the New England Journal of Medicine. The study, based on a detailed review of pneumococcal meningitis cases, also noted an increase in strains of pneumococcal meningitis not susceptible to the vaccine and those resistant to antibiotics.